{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:26:18Z","timestamp":1790245578241,"version":"4.1.0"},"reference-count":0,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood"],"published-print":{"date-parts":[[2004,5,1]]},"DOI":"10.1182\/blood-2003-08-2764","type":"journal-article","created":{"date-parts":[[2004,1,19]],"date-time":"2004-01-19T20:14:24Z","timestamp":1074543264000},"page":"3271-3277","source":"Crossref","is-referenced-by-count":141,"title":["Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic\/tumor survival pathways in patients with advanced multiple myeloma"],"prefix":"10.1182","volume":"103","author":[{"given":"M.","family":"Alsina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","container-title":["Blood"],"original-title":[],"language":"en","deposited":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T20:55:48Z","timestamp":1313268948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bloodjournal.org\/cgi\/doi\/10.1182\/blood-2003-08-2764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-08-2764","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}